Collectively, these findings suggest that the expression of CD16 facilitates the differentiation of monocytes toward osteoclasts and that CD16 could represent a marker of osteoclast precursors in CLL, as was previously indicated for psoriatic arthritis [67]. This evidence concerns the gene FCGR3A and B-cell chronic lymphocytic leukemia.